Allan D. Struthers

Allan D. Struthers's AcademicInfluence.com Rankings

Allan D. Struthers

Engineering

#2889

World Rank

#3882

Historical Rank

Electrical Engineering

#578

World Rank

#637

Historical Rank

engineering Degrees

Allan D. Struthers

Computer Science

#3845

World Rank

#4041

Historical Rank

Computational Linguistics

#268

World Rank

#272

Historical Rank

Machine Learning

#575

World Rank

#582

Historical Rank

Artificial Intelligence

#777

World Rank

#789

Historical Rank

computer-science Degrees

Download Badge

Engineering
Computer Science

Allan D. Struthers's Degrees

PhD Computer Science Stanford University
Masters Electrical Engineering University of California, Berkeley
Bachelors Computer Engineering University of California, Berkeley

Similar Degrees You Can Earn

Best Online PhD of Computer Science (Doctorates) 2025

Why Is Allan D. Struthers Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Allan D. Struthers's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) (1999) (4830)
QT dispersion and sudden unexpected death in chronic heart failure (1994) (811)
Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels (2008) (570)
High-Dose Allopurinol Improves Endothelial Function by Profoundly Reducing Vascular Oxidative Stress and Not by Lowering Uric Acid (2006) (561)
Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure. (2000) (526)
Allopurinol Improves Endothelial Dysfunction in Chronic Heart Failure (2002) (514)
Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. (2000) (491)
Effect of vitamin D on blood pressure: a systematic review and meta-analysis (2009) (372)
Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients. (1997) (358)
Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial (2010) (336)
Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease. (1995) (335)
What is the optimal serum potassium level in cardiovascular patients? (2004) (317)
Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study (2002) (304)
Pulse wave analysis and pulse wave velocity: a critical review of their strengths and weaknesses (2003) (300)
Effect of Vitamin D Supplementation on Blood Pressure: A Systematic Review and Meta-analysis Incorporating Individual Patient Data. (2015) (264)
Review of aldosterone- and angiotensin II-induced target organ damage and prevention. (2004) (249)
Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction (1993) (244)
Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure. (1996) (234)
Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy. (2002) (231)
The effect of different doses of vitamin D3 on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial (2010) (227)
Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial (2007) (220)
Heart failure in frail elderly patients: diagnostic difficulties, co‐morbidities, polypharmacy and treatment dilemmas (2002) (219)
The Effects of Vitamin D Supplementation on Physical Function and Quality of Life in Older Patients With Heart Failure: A Randomized Controlled Trial (2010) (212)
How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure? (1999) (211)
Human calcitonin gene related peptide: a potent endogenous vasodilator in man. (1986) (210)
Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. (1996) (208)
Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress (2009) (191)
Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods. (1994) (186)
Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease. (2011) (183)
Echocardiography in chronic heart failure in the community. (1993) (171)
Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure. (2001) (169)
C-Type Natriuretic Peptide (1996) (167)
The effect of different doses of vitamin D 3 on markers of vascular health in patients with type 2 diabetes : a randomised controlled trial (2010) (163)
Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice. (2012) (163)
High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort. (2014) (159)
QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: cohort study (1998) (155)
Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial. (2013) (154)
High-dose allopurinol reduces left ventricular mass in patients with ischemic heart disease. (2013) (151)
Impact of renin-angiotensin system blockade therapy on outcome in aortic stenosis. (2011) (147)
Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment (2004) (143)
Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction. (1996) (143)
Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics. (1989) (143)
Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study (2002) (141)
A Comparison of the Aldosterone‐blocking Agents Eplerenone and Spironolactone (2008) (135)
More than skin deep: atherosclerosis as a systemic manifestation of psoriasis (2009) (133)
N-terminal pro-brain natriuretic protein levels in takotsubo cardiomyopathy. (2011) (128)
PRIOR THIAZIDE DIURETIC TREATMENT INCREASES ADRENALINE-INDUCED HYPOKALAEMIA (1983) (127)
Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI) (2014) (127)
Adverse Cardiovascular Effects of Acute Salt Loading in Young Normotensive Individuals (2008) (125)
Aldosterone escape during ACE inhibitor therapy in chronic heart failure. (1995) (125)
Effect of intravenous adrenaline on electrocardiogram, blood pressure, and serum potassium. (1983) (125)
Myocardial Production of C-Type Natriuretic Peptide in Chronic Heart Failure (2003) (123)
Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris. (2011) (122)
The effects of cardioselective and non-selective beta-adrenoceptor blockade on the hypokalaemic and cardiovascular responses to adrenomedullary hormones in man. (1983) (115)
The effect of vitamin D replacement on markers of vascular health in stroke patients - a randomised controlled trial. (2012) (114)
Allopurinol reduces left ventricular mass in patients with type 2 diabetes and left ventricular hypertrophy. (2013) (114)
Cardiovascular Effects of Switching From Tobacco Cigarettes to Electronic Cigarettes (2019) (114)
The clinical implications of aldosterone escape in congestive heart failure (2004) (112)
Spironolactone impairs endothelial function and heart rate variability in patients with Type 2 diabetes (2004) (112)
Atrial and brain natriuretic peptides: a dual natriuretic peptide system potentially involved in circulatory homeostasis. (1992) (110)
DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans. (1999) (110)
Peripheral blood pressure measurement is as good as applanation tonometry at predicting ascending aortic blood pressure (2003) (108)
Effect of a seated exercise program to improve physical function and health status in frail patients > or = 70 years of age with heart failure. (2005) (107)
Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure (2005) (106)
Atrial natriuretic peptide inhibits the aldosterone response to angiotensin II in man. (1986) (106)
The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus (2005) (105)
A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial (2020) (104)
Cross sectional study of contribution of clinical assessment and simple cardiac investigations to diagnosis of left ventricular systolic dysfunction in patients admitted with acute dyspnoea (1997) (103)
Impact of allopurinol use on urate concentration and cardiovascular outcome (2011) (100)
Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial (2002) (100)
Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure. (2009) (98)
Day length and weather conditions profoundly affect physical activity levels in older functionally impaired people (2008) (98)
Epinephrine-induced hypokalemia: the role of beta adrenoceptors. (1986) (97)
Spironolactone use and renal toxicity: population based longitudinal analysis (2010) (96)
Social deprivation increases cardiac hospitalisations in chronic heart failure independent of disease severity and diuretic non-adherence (2000) (96)
Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular disease (1996) (93)
Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction. (1994) (93)
Elevated levels of brain natriuretic peptide in acute hypoxaemic chronic obstructive pulmonary disease. (1992) (92)
Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial. (2014) (91)
Assessment of arterial stiffness, a translational medicine biomarker system for evaluation of vascular risk. (2008) (91)
Effect of Metformin on mortality in patients with heart failure and type 2 diabetes mellitus. (2010) (89)
Anaemia in chronic heart failure: what is its frequency in the UK and its underlying causes? (2002) (89)
The effect of metformin on insulin resistance and exercise parameters in patients with heart failure (2012) (88)
Recommendations for the Management of Intracranial Haemorrhage – Part I: Spontaneous Intracerebral Haemorrhage (2006) (87)
A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial (2019) (86)
Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping (2016) (85)
Targeting the renin–angiotensin–aldosterone system in heart failure (2013) (85)
Aldosterone: cardiovascular assault. (2002) (83)
Improving the primary prevention of cardiovascular events by using biomarkers to identify individuals with silent heart disease. (2012) (82)
The effect of the neutral endopeptidase inhibitor drug, candoxatril, on circulating levels of two of the most potent vasoactive peptides. (2003) (82)
Left Ventricular Noncompaction (2016) (80)
Dapagliflozin Versus Placebo on Left Ventricular Remodeling in Patients With Diabetes and Heart Failure: The REFORM Trial (2020) (80)
Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study (1999) (79)
QT dispersion in patients with chronic heart failure: β blockers are associated with a reduction in QT dispersion (1999) (78)
QT interval abnormalities are often present at diagnosis in diabetes and are better predictors of cardiac death than ankle brachial pressure index and autonomic function tests (2004) (77)
Cutaneous Vascular Responses to Acetylcholine are Mediated by a Prostanoid-Dependent Mechanism in Man (1997) (77)
Myocardial production of C-type natriuretic peptide in chronic heart failure. (2003) (76)
Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure (2020) (76)
Introducing a new role for BNP: as a general indicator of cardiac structural disease rather than a specific indicator of systolic dysfunction only (2002) (75)
Effects of vitamin D supplementation on markers of vascular function after myocardial infarction--a randomised controlled trial. (2013) (75)
Dietary sodium loading increases plasma brain natriuretic peptide levels in man. (1991) (74)
Cardiopulmonary effects of endothelin-1 in man. (1997) (72)
Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles (2008) (71)
The potential to improve primary prevention in the future by using BNP/N-BNP as an indicator of silent 'pancardiac' target organ damage: BNP/N-BNP could become for the heart what microalbuminuria is for the kidney. (2007) (70)
Calcium antagonists and hormone release. (1984) (70)
Effect of haemodialysis on plasma levels of brain natriuretic peptide in patients with chronic renal failure. (1992) (69)
Mean HbA1c and mortality in diabetic individuals with heart failure: a population cohort study (2016) (68)
Importance of Potassium in Cardiovascular Disease (2002) (68)
Effect of Vitamin D Supplementation on Markers of Vascular Function: A Systematic Review and Individual Participant Meta‐Analysis (2018) (67)
The neurohormonal natural history of essential hypertension: towards primary or tertiary aldosteronism? (2002) (66)
Gradual reactivation over time of vascular tissue angiotensin I to angiotensin II conversion during chronic lisinopril therapy in chronic heart failure. (2002) (65)
Vitamin D Therapy to Reduce Blood Pressure and Left Ventricular Hypertrophy in Resistant Hypertension: Randomized, Controlled Trial (2014) (64)
The impact of renin-angiotensin-aldosterone system blockade on heart failure outcomes and mortality in patients identified to have aortic regurgitation: a large population cohort study. (2011) (64)
Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART study (2016) (64)
Fortnightly Review: Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use? (1994) (63)
The role of urate and xanthine oxidase inhibitors in cardiovascular disease. (2008) (63)
The effect of intravenous saline loading on plasma levels of brain natriuretic peptide in man (1993) (61)
The renal and cardiovascular effects of SGLT2 inhibition in combination with loop diuretics in patients with type 2 diabetes and chronic heart failure (RECEDE-CHF) trial (2020) (61)
A comparison between B-type natriuretic peptide, Global Registry of Acute Coronary Events (GRACE) score and their combination in ACS risk stratification (2009) (60)
Clearance of brain natriuretic peptide in patients with chronic heart failure: indirect evidence for a neutral endopeptidase mechanism but against an atrial natriuretic peptide clearance receptor mechanism. (1992) (60)
The morning surge in blood pressure and heart rate is dependent on levels of physical activity after waking (2002) (60)
Urate predicts subsequent cardiac death in stroke survivors. (2002) (59)
Pulmonary hypertension predicts all‐cause mortality in patients with heart failure: a retrospective cohort study (2012) (58)
The role of C-type natriuretic peptide in cardiovascular medicine. (2001) (58)
Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisal. (2012) (58)
Allopurinol treatment reduces arterial wave reflection in stroke survivors. (2008) (57)
Long QTc predicts future cardiac death in stroke survivors (2003) (57)
Efficacy and Cost of an Exercise Program for Functionally Impaired Older Patients With Heart Failure: A Randomized Controlled Trial (2012) (56)
A Multicenter, Randomized, Placebo‐Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis (2019) (56)
Do ACE Inhibitors Improve the Response to Exercise Training in Functionally Impaired Older Adults? A Randomized Controlled Trial (2013) (55)
B-type natriuretic peptide can detect silent myocardial ischaemia in asymptomatic type 2 diabetes (2005) (55)
Left Ventricular Noncompaction Anatomical Phenotype or Distinct Cardiomyopathy ? (2016) (54)
The clinical implications of diabetic heart disease. (1998) (54)
Twenty‐Year Predictors of Peripheral Arterial Disease Compared With Coronary Heart Disease in the Scottish Heart Health Extended Cohort (SHHEC) (2017) (53)
Association between allopurinol and mortality in heart failure patients: a long‐term follow‐up study (2009) (52)
Angiotensin-converting enzyme gene polymorphism and cardiovascular disease. (1997) (52)
Research into the effect Of SGLT2 inhibition on left ventricular remodelling in patients with heart failure and diabetes mellitus (REFORM) trial rationale and design (2016) (52)
Enalapril reduces QTc dispersion in mild congestive heart failure secondary to coronary artery disease. (1997) (51)
The role of adrenal medullary catecholamines in potassium homoeostasis. (1984) (51)
Hormonal and renal differences between low dose and high dose angiotensin converting enzyme inhibitor treatment in patients with chronic heart failure. (1996) (51)
N-terminal proatrial natriuretic peptide and brain natriuretic peptide are stable for up to 6 hours in whole blood in vitro. (1995) (51)
C-type natriuretic peptide levels in cor pulmonale and in congestive heart failure. (1994) (50)
Predictors of exercise capacity and everyday activity in older heart failure patients (2006) (49)
Exercise Training as a Therapy for Chronic Heart Failure: Can Older People Benefit? (2003) (49)
C-type natriuretic peptide. An endogenous inhibitor of vascular angiotensin-converting enzyme activity. (1996) (49)
Abnormal myocardial repolarisation in response to hypoxaemia and fenoterol. (1995) (48)
Angiotensin II augments sympathetically mediated arteriolar constriction in man. (1991) (48)
Furosemide‐Induced Natriuresis Is Augmented by Ultra‐Low‐Dose Captopril but Not by Standard Doses of Captopril in Chronic Heart Failure (1992) (47)
The physiological and pharmacological role of presynaptic alpha- and beta-adrenoceptors in man. (1985) (46)
Spironolactone has antiarrhythmic activity in ischaemic cardiac patients without cardiac failure (2007) (46)
Renin–Angiotensin–Aldosterone System Inhibitors in Heart Failure (2013) (46)
Relation of QT interval dispersion to the number of different cardiac abnormalities in diabetes mellitus. (2002) (46)
Renal and Cardiovascular Effects of sodium–glucose cotransporter 2 (SGLT2) inhibition in combination with loop Diuretics in diabetic patients with Chronic Heart Failure (RECEDE-CHF): protocol for a randomised controlled double-blind cross-over trial (2017) (45)
Sudden unexpected death in heart failure may be preceded by short term, intraindividual increases in inflammation and in autonomic dysfunction: a pilot study (2004) (45)
Sarcopenia – A Potential Target for Angiotensin-Converting Enzyme Inhibition? (2006) (45)
The functional consequence of the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene in young healthy volunteers. (2007) (45)
Effect of vitamin K on vascular health and physical function in older people with vascular disease–a randomised controlled trial (2016) (45)
The role of pulmonary arterial stiffness in COPD (2015) (44)
Increasing plasma potassium with amiloride shortens the QT interval and reduces ventricular extrasystoles but does not change endothelial function or heart rate variability in chronic heart failure (2002) (44)
Why does spironolactone improve mortality over and above an ACE inhibitor in chronic heart failure? (1999) (44)
Both High and Low HbA1c Predict Incident Heart Failure in Type 2 Diabetes Mellitus (2015) (43)
Prior treatment with diuretic augments the hypokalemic and electrocardiographic effects of inhaled albuterol. (1989) (43)
A randomized, double-blind, placebo-controlled study to determine the effects of valsartan on exercise time in patients with symptomatic heart failure with preserved ejection fraction (2009) (42)
Meta-analysis of B-type natriuretic peptide's ability to identify stress induced myocardial ischemia. (2011) (41)
Left ventricular hypertrophy: reduction of blood pressure already in the normal range further regresses left ventricular mass (2009) (41)
Lack of rapid aldosterone effects on forearm resistance vasculature in health (2002) (41)
Leucine and ACE inhibitors as therapies for sarcopenia (LACE trial): study protocol for a randomised controlled trial (2018) (40)
Pathophysiology of heart failure following myocardial infarction (2005) (39)
The prevalence of treatable left ventricular systolic dysfunction in patients who present with noncardiac vascular episodes: a case-control study. (2002) (39)
Aldosterone blockade in cardiovascular disease (2004) (39)
Cyclosporin‐induced hypertension precedes renal dysfunction and sodium retention in man (1993) (39)
Cigarette smoking in men and vascular responsiveness. (2001) (39)
ACE inhibitors as a therapy for sarcopenia — Evidence and possible mechanisms (2008) (38)
Spironolactone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients. (2005) (38)
Adverse Cardiac Effects of Salt With Fludrocortisone in Hypertension (2001) (38)
B-type natriuretic peptide in the diagnosis of cardiac disease in elderly day hospital patients. (2002) (37)
Mineralocorticoid antagonism: a novel way to treat sarcopenia and physical impairment in older people? (2011) (37)
Aldosterone-induced vasculopathy (2004) (37)
Adherence to angiotensin‐converting‐enzyme inhibitors and illness beliefs in older heart failure patients (2009) (36)
Glucose Tolerance During Antihypertensive Therapy in Patients with Diabetes Mellitus (1985) (36)
Effects of an exercise intervention for older heart failure patients on caregiver burden and emotional distress (2006) (35)
Impact of aldosterone on vascular pathophysiology. (2002) (35)
Prospects for using a blood sample in the diagnosis of heart failure. (1995) (35)
Elevated levels of natriuretic peptides in patients with pulmonary thromboembolism. (2005) (34)
Effect of nifedipine on blood pressure and adrenocortical responses to trophic stimuli in humans. (1982) (34)
The effect of prazosin on skin microcirculation as assessed by laser Doppler flowmetry. (1988) (34)
Plasma concentrations of brain natriuretic peptide: will this new test reduce the need for cardiac investigations? (1993) (33)
Calcium antagonists and hormone release: effect of nifedipine on luteinizing hormone-releasing hormone and thyrotropin-releasing hormone-induced pituitary hormone release. (1983) (33)
Vitamin K Supplementation to Improve Vascular Stiffness in CKD: The K4Kidneys Randomized Controlled Trial. (2020) (33)
Sympathetically mediated vasoconstriction is augmented by angiotensin II in man (1988) (33)
Brain natriuretic peptide concentrations in patients with aortic stenosis. (1997) (33)
Effects of Exogenous and Endogenous Natriuretic Peptides on Forearm Vascular Function in Chronic Heart Failure (2004) (32)
Left ventricular hypertrophy in COPD without hypoxemia: the elephant in the room? (2013) (32)
Therapeutic development in cardiac syndrome X: a need to target the underlying pathophysiology. (2009) (32)
Does the ratio of serum aldosterone to plasma renin activity predict the efficacy of diuretics in hypertension? Results of RENALDO (2010) (32)
Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities. (2009) (32)
Lisinopril improves endothelial function in chronic cigarette smokers. (2001) (30)
Evidence in humans for a postsynaptic interaction between noradrenaline and angiotensin II with regard to systolic but not diastolic blood pressure. (1987) (30)
Serial changes in blood pressure, renal function, endothelin and lipoprotein (a) during the first 9 days of cyclosporin therapy in males (1995) (29)
Using the demand-control model of job strain to predict caregiver burden and caregiver satisfaction in the informal caregivers of heart failure patients. (2008) (29)
The association between serum urate levels and arterial stiffness/endothelial function in stroke survivors. (2008) (29)
Exercise-induced increases in plasma catecholamines and growth hormone are augmented by selective alpha 2-adrenoceptor blockade in man. (1986) (28)
Furosemide responsiveness, non-adherence and resistance during the chronic treatment of heart failure: a longitudinal study. (2004) (28)
Hypokalemic and ECG sequelae of combined beta-agonist/diuretic therapy. Protection by conventional doses of spironolactone but not triamterene. (1990) (28)
The diagnosis of heart failure (2000) (28)
Nonadherence with angiotensin-converting enzyme inhibitor therapy: a comparison of different ways of measuring it in patients with chronic heart failure. (1999) (28)
How to use natriuretic peptide levels for diagnosis and prognosis. (1999) (28)
B-type natriuretic peptide: a simple new test to identify coronary artery disease? (2005) (28)
Are Natriuretic Peptides Clinically Useful as Markers of Heart Failure? (2001) (28)
Allopurinol: novel indications in cardiovascular disease (2012) (27)
Hypertensive left ventricular hypertrophy: a mechanistic approach to optimizing regression assessed by cardiovascular magnetic resonance (2012) (27)
Tolerability of spironolactone in patients with chronic heart failure -- a cautionary message. (2004) (27)
The role of urate and xanthine oxidase in vascular oxidative stress: future directions (2009) (27)
B-type natriuretic Peptide is associated with both augmentation index and left ventricular mass in diabetic patients without heart failure. (2005) (27)
The cardiovascular risk factor, left ventricular hypertrophy, is highly prevalent in stable, treated angina pectoris. (2007) (27)
Systemic beta-adrenoceptor responses to salbutamol given by metered-dose inhaler alone and with pear shaped spacer attachment: comparison of electrocardiographic, hypokalaemic and haemodynamic effects. (1989) (27)
Rapid changes in plasma potassium during a game of squash. (1988) (27)
B-type natriuretic peptide identifies silent myocardial ischaemia in stroke survivors (2005) (26)
Human C-type natriuretic peptide: effects on the haemodynamic and endocrine responses to angiotensin II. (1995) (26)
Non-adherence with ACE inhibitor treatment is common in heart failure and can be detected by routine serum ACE activity assays (1999) (25)
Dose-response study of the redistribution of intravascular volume by angiotensin II in man. (1992) (25)
B-type natriuretic peptide is an independent predictor of endothelial function in man (2012) (24)
Natriuretic peptides as a prognostic marker and therapeutic target in heart failure (2005) (24)
Acute effects of captopril on the renal actions of furosemide in patients with chronic heart failure. (1993) (24)
Atrial natriuretic peptide increases urinary albumin excretion in men with Type 1 diabetes mellitus and established microalbuminuria (1998) (24)
Is there a role for renin profiling in selecting chronic heart failure patients for ACE inhibitor treatment? (2000) (24)
Xanthine oxidase inhibition for the improvement of long-term outcomes following ischaemic stroke and transient ischaemic attack (XILO-FIST) – Protocol for a randomised double blind placebo-controlled clinical trial (2018) (24)
Lisinopril improves arterial function in hyperlipidaemia. (1999) (24)
Non-steroidal anti-inflammatory drugs and angiotensin converting enzyme inhibitors: a commonly prescribed combination with variable effects on renal function. (1993) (24)
Investigation in general practice of patients with suspected heart failure. How should the essential echocardiographic service be delivered? (1995) (23)
Prediction of response to theophylline in chronic bronchitis. (1984) (23)
The choice of antihypertensive therapy in the diabetic patient. (1985) (23)
Intensive statin treatment improves baroreflex sensitivity: another cardioprotective mechanism for statins? (2002) (23)
Natriuretic response to neutral endopeptidase inhibition is blunted by enalapril in healthy men. (1995) (23)
Polymorphisms of the angiotensin converting enzyme gene in early-onset and late-onset pre-eclampsia (2010) (22)
Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension (2016) (22)
Effects of aldosterone on forearm vasculature in treated chronic heart failure. (2005) (22)
Atrial Natriuretic Peptide Regulates Regional Vascular Volume and Venous Tone in Humans (2003) (22)
Hormonal and other mechanisms involved in the pathogenesis of cyclosporin-induced nephrotoxicity and hypertension in man. (1994) (22)
Angiotensin converting enzyme activity in infancy is related to birth weight (2004) (22)
Biological variation of urinary magnesium. (1991) (22)
Does dapagliflozin regress left ventricular hypertrophy in patients with type 2 diabetes? A prospective, double-blind, randomised, placebo-controlled study (2017) (22)
Indomethacin and cyclosporin together produce marked renal vasoconstriction in humans (1994) (21)
Do Losartan and Atenolol have Differential Effects on BNP and Central Haemodynamic Parameters? (2005) (21)
Beyond blood pressure: pulse wave analysis--a better way of assessing cardiovascular risk? (2005) (21)
Reversible hypertension following coeliac disease treatment: the role of moderate hyperhomocysteinaemia and vascular endothelial dysfunction (2002) (21)
Technical assessment of whole body angiography and cardiac function within a single MRI examination (2015) (21)
Effect of spironolactone on C-reactive protein levels in patients with heart disease. (2007) (21)
Modulation of the Renin-Angiotensin-Aldosterone System in Heart Failure (2014) (20)
The prognostic value of high sensitivity troponin T 7 weeks after an acute coronary syndrome (2012) (20)
Aortic remodelling following the treatment and regression of hypertensive left ventricular hypertrophy: a cardiovascular magnetic resonance study (2015) (20)
B-type natriuretic peptide as an alternative way of assessing total cardiovascular risk in patients with diabetes mellitus. (2005) (20)
Family history of premature coronary heart disease and risk prediction (2011) (20)
Preoperative NT-proBNP and CRP predict perioperative major cardiovascular events in non-cardiac surgery (2010) (20)
Comparative effects of atrial natriuretic peptide and brain natriuretic peptide on the aldosterone and pressor responses to angiotensin II in man. (1995) (19)
Allopurinol treatment adversely impacts left ventricular mass regression in patients with well-controlled hypertension (2019) (19)
B‐Type Natriuretic Peptide Is Associated with Mortality in Older Functionally Impaired Patients (2005) (19)
Common Carotid Intima Media Thickness and Ankle-Brachial Pressure Index Correlate with Local but Not Global Atheroma Burden: A Cross Sectional Study Using Whole Body Magnetic Resonance Angiography (2014) (19)
Right coronary artery stenosis is associated with impaired cardiac endocrine function during exercise. (1997) (19)
A critical re‐appraisal of different ways of selecting ambulatory patients with suspected heart failure for echocardiography (2007) (18)
Serial changes in adiponectin and BNP in ACS patients: paradoxical associations with each other and with prognosis. (2009) (18)
The prognostic significance of early and late anaemia in acute coronary syndrome. (2012) (18)
Angiotensin II receptor antagonists for heart failure (1998) (18)
The OPT-CHF (Oxypurinol Therapy for Congestive Heart Failure) trial: a question of dose. (2009) (18)
Systemic nitric oxide synthase inhibition increases insulin sensitivity in man. (1998) (18)
Myocardial fibrosis and QTc are reduced following treatment with spironolactone or amiloride in stroke survivors: a randomised placebo-controlled cross-over trial. (2013) (18)
Uric acid in chronic heart failure—current pathophysiological concepts * (2008) (17)
Prevalence of unrecognized myocardial infarction in a low–intermediate risk asymptomatic cohort and its relation to systemic atherosclerosis (2016) (17)
Sequential effects of cyclosporine therapy on blood pressure, renal function and neurohormones. (1994) (17)
Adrenaline, Hypokalaemia and Cardiac Arrhythmias: Effects of Beta Adrenoceptor Antagonists (1982) (17)
Metabolic and haemodynamic effects of alpha 2-adrenoceptor stimulation and antagonism in man. (1985) (17)
High-potency statin and ezetimibe use and mortality in survivors of an acute myocardial infarction: a population-based study (2014) (17)
Effect of Spironolactone on Physical Performance in Older People with Self-reported Physical Disability (2013) (17)
Evidence for a proximal and distal nephron action of atrial natriuretic factor in man. (1989) (17)
Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial (2022) (17)
Mechanisms of the antinatriuretic action of physiological doses of angiotensin II in man. (1989) (17)
Effect of Social Deprivation on Mortality and the Duration of Hospital Stay after a Stroke (2006) (17)
Correlation of angiotensin converting enzyme activity and the genotypes of the I/D polymorphism in the ACE gene with preterm birth and birth weight. (2008) (17)
Differential expression and synthesis of natriuretic peptides determines natriuretic peptide receptor expression in primary cultures of human proximal tubular cells (2001) (16)
Exercise Capacity and Brain Natruiretic Peptide in Hypertension (2002) (16)
Long-term follow-up of very old heart failure patients enrolled in a trial of exercise training. (2007) (16)
Regulation of regional vascular tone: the role of angiotensin conversion in human forearm resistance vessels. (1988) (16)
Effect of vitamin D supplementation on orthostatic hypotension: data from the Vitamin D in Isolated Systolic Hypertension randomized controlled trial (2014) (16)
Tachyphylaxis to Systemic but Not Airways Responses during Prolonged Therapy with High Dose Inhaled Salbutamol in Asthmatics (1989) (16)
Atrial natriuretic factor improves renal function and lowers systolic blood pressure in renal allograft recipients treated with cyclosporin A. (1992) (16)
3T MRI investigation of cardiac left ventricular structure and function in a UK population: The tayside screening for the prevention of cardiac events (TASCFORCE) study (2016) (16)
Aldosterone in heart failure: Pathophysiology and treatment (2004) (16)
Sex differences in hypokalaemic and electrocardiographic effects of inhaled terbutaline. (1992) (16)
A New Approach to Residual Risk in Treated Hypertension—3P Screening (2013) (16)
Evaluation of the aldosterone-blocking agent eplerenone in hypertension and heart failure (2007) (16)
Nonadherence with ACE inhibitors is common and can be detected in clinical practice by routine serum ACE activity. (2001) (16)
Metabolic and haemodynamic effects of increased circulating adrenaline in man. Effect of labetalol, an alpha and beta blocker. (1983) (16)
The practical assessment of compliance with ACE-inhibitor therapy--a novel approach. (1997) (15)
Brain natriuretic peptide. (1994) (15)
C-Type Natriuretic Peptide: An Endogenous Inhibitor of Vascular Angiotensin-Converting Enzyme Activity (1995) (15)
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial (2022) (15)
Spectrum of cardiac abnormalities associated with long QT in stroke survivors (2005) (15)
Age is not a significant risk factor for failed trial of beta-blocker therapy in older patients with chronic heart failure. (2004) (15)
Nitric oxide: an important role in the maintenance of systemic and pulmonary vascular tone in man. (1998) (15)
Mean HbA 1 c and mortality in diabetic individuals with heart failure : a population cohort study (2016) (15)
Aldosterone Blockade Over and Above ACE-Inhibitors in Patients with Coronary Artery Disease but without Heart Failure (2006) (14)
A Randomized Controlled Trial of Allopurinol in Patients With Peripheral Arterial Disease (2016) (14)
Dose‐ranging effects of candoxatril on elimination of exogenous atrial natriuretic peptide in chronic heart failure (1993) (14)
Genetic variants predicting left ventricular hypertrophy in a diabetic population: a Go-DARTS study including meta-analysis (2013) (14)
Are natriuretic peptides clinically useful as markers of heart failure? (2001) (14)
Physiology of aldosterone and pharmacology of aldosterone blockers (2011) (14)
Self-Assessment of Medical Knowledge: Do Physicians Overestimate or Underestimate? (1991) (14)
Cyclosporin-induced renal vasoconstriction is augmented by frusemide and by angiotensin II in humans (1995) (13)
Screening for left ventricular systolic dysfunction in patients with stroke, transient ischaemic attacks, and peripheral vascular disease. (1999) (13)
A placebo-controlled study examining the effect of allopurinol on heart rate variability and dysrhythmia counts in chronic heart failure. (2001) (13)
Hypothetical economic analysis of screening for left ventricular hypertrophy in high-risk normotensive populations. (2004) (13)
Insulin sensitization therapy and the heart: focus on metformin and thiazolidinediones. (2012) (13)
C-type natriuretic peptide production by the human kidney is blunted in chronic heart failure. (2009) (13)
Effect of angiotensin-converting enzyme inhibition on plasma brain natriuretic peptide levels in patients with heart failure. (1992) (13)
Hyperuricemia and Adverse Outcomes in Cardiovascular Disease (2003) (13)
The plasma noradrenaline and growth hormone response to alpha-methyldopa and clonidine in hypertensive subjects. (1985) (12)
Hyperuricemia and adverse outcomes in cardiovascular disease: potential for therapeutic intervention. (2003) (12)
Review: Aldosterone-induced vasculopathy: a new reversible cause of cardiac death (2001) (12)
Effect of noradrenaline on renal sodium and water handling in euhydrated and overhydrated man. (1993) (12)
Time course for recovery of atrial mechanical and endocrine function post DC cardioversion for persistent atrial fibrillation. (2005) (12)
The effect of angiotensin II on endogenous noradrenaline release in man. (1987) (12)
Neuroendocrine changes post myocardial infarction: effects of xamoterol. (1990) (12)
Left ventricular hypertrophy is present in one-half of newly-diagnosed peripheral arterial disease patients (2007) (12)
The interaction between noradrenaline and angiotensin II in man: evidence for a postsynaptic and against a presynaptic interaction. (1987) (12)
Aldosterone blockade in heart failure (2004) (12)
Interactions between atrial natriuretic factor and the autonomic nervous system (1991) (11)
Digoxin‐specific Fab fragments impair renal function in the rat (1992) (11)
Effectiveness of captopril in reversing renal vasoconstriction after Q-wave acute myocardial infarction. (1993) (11)
Screening for left ventricular systolic dysfunction using GP-reported ECGs. (2007) (11)
A Survey of Current Use of Angiotensin-Converting-Enzyme Inhibitors by Scottish Physicians in the Treatment of Chronic Cardiac Failure (1989) (11)
Practical issues when initiating captopril therapy in chronic heart failure. What is the appropriate dose and how long should patients be observed? (1992) (11)
Effects of captopril and enalapril on renal function in elderly patients with chronic heart failure. (1995) (11)
Heart rate variability as an indicator of left ventricular systolic dysfunction (2009) (11)
Development and validation of a clinical score to identify echocardiographic left ventricular hypertrophy in patients with cardiovascular disease. (2008) (11)
Mineralocorticoid receptor blockade in chronic heart failure. (1995) (11)
Development and Validation of a Path Length Calculation for Carotid–Femoral Pulse Wave Velocity Measurement (2018) (11)
Hyperkalemia after the publication of RALES. (2004) (11)
An Increased B-Type Natriuretic Peptide in the Absence of a Cardiac Abnormality Identifies Those Whose Left Ventricular Mass Will Increase Over Time (2015) (11)
The effect of perindopril on postural instability in older people with a history of falls—a randomised controlled trial (2017) (11)
Respiratory function measurements in clinical pharmacological studies including an assessment of the area under the MEFV curve as a new parameter in chronic bronchitic patients (2004) (11)
Enalapril blunts the antinatriuretic effect of circulating noradrenaline in man (1993) (11)
Gradual reactivation of vascular angiotensin I to angiotensin II conversion during chronic ACE inhibitor therapy in patients with diabetes mellitus (2007) (10)
How much echo left ventricular hypertrophy would be missed in diabetics by applying the Losartan Intervention For Endpoint Reduction electrocardiogram criteria to select patients for angiotensin receptor blockade? (2004) (10)
Noradrenaline attenuates the natriuretic effect of atrial natriuretic factor in man. (1989) (10)
Physiological increases in circulating noradrenaline are antinatriuretic in man. (1988) (10)
Right ventricular pacing impairs endothelial function in man. (2011) (10)
Development of persistent late onset asthma following treatment with captopril. (1989) (10)
The clinical pharmacology of angiotensin converting enzyme inhibitors in chronic heart failure. (1992) (10)
Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in Patients with asthma (1989) (10)
Effects of lisinopril on congestive heart failure in normotensive patients with diastolic dysfunction but intact systolic function (2004) (10)
Two new culprits in cardiovascular disease: QT dispersion and aldosterone. (1995) (10)
Effect of centrally acting alpha-adrenergic agonists on sympathetic nervous system function in humans. (1984) (10)
Renal, hemodynamic and neurohormonal effects of atrial natriuretic factor in cardiac allograft recipients treated with cyclosporin A. (1993) (10)
Further evidence that chronic perindopril treatment maintains neurohormonal suppression but does not lower blood pressure in chronic cardiac failure. (2003) (10)
Aortic valvular heart disease: is there a place for angiotensin-converting-enzyme inhibitors? (2013) (10)
Prazosin attenuates the natriuretic response to atrial natriuretic factor in man. (1992) (10)
High BNP levels in rheumatoid arthritis are related to inflammation but not to left ventricular abnormalities: a prospective case-control study. (2014) (9)
Central nervous system mechanisms in blood pressure control (2004) (9)
Effect of nifedipine on bronchomotor tone and histamine reactivity in asthma (1981) (9)
Pulmonary arterial stiffening in COPD and its implications for right ventricular remodelling (2018) (9)
A new use for B-type natriuretic peptide: to detect myocardial ischaemia in non-heart failure patients (2010) (9)
Adrenaline causes hypokalaemia in man by beta 2 adrenoceptor stimulation. (1984) (9)
Rationalizing the heart failure trials: from theory to practice. (1997) (9)
Immediately postoperative B-type natriuretic peptide and its predictive value. (2011) (9)
Could BNP screening of acute chest pain cases lead to safe earlier discharge of patients with non-cardiac causes? A pilot study. (2007) (9)
Prazosin blunts the antinatriuretic effect of circulating angiotensin II in man (1992) (9)
Review: Vasopeptidase inhibitors in heart failure (2002) (9)
Electrocardiographic changes induced by inhaled salbutamol after treatment with bendrofluazide: effects of replacement therapy with potassium, magnesium and triamterene. (1990) (9)
Screening for treatable left ventricular abnormalities in diabetic patients (2003) (9)
Angiotensin blockade or aldosterone blockade as the third neuroendocrine-blocking drug in mild but symptomatic heart failure patients (2005) (9)
Myocardial ischaemia is associated with an elevated brain natriuretic pepide level even in the presence of left ventricular systolic dysfunction (2014) (9)
Further defining the role for natriuretic peptide levels in clinical practice. (1999) (9)
The Incidence and Risk of Biochemical Recurrence Following Radical Radiotherapy for Prostate Cancer in Men on Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin Receptor Blockers (ARBs). (2016) (8)
Raised plasma concentrations of brain natriuretic peptide in pulmonary arterial hypertension. (1995) (8)
Ovarian hormones in man: their effects on resting vascular tone, angiotensin converting enzyme activity and angiotensin II-induced vasoconstriction. (2000) (8)
The APEX trial: Effects of allopurinol on exercise capacity, coronary and peripheral endothelial function, and natriuretic peptides in patients with cardiac syndrome X (2018) (8)
Metformin Regresses Left Ventricular Hypertrophy in Normotensive Patients with Coronary Artery Disease without Type 2 Diabetes Mellitus—The MET-REMODEL Trial (2018) (8)
Effect of pericardiocentesis on plasma levels of brain natriuretic peptide in cardiac tamponade. (1992) (8)
Interactive effects of indomethacin, angiotensin II and frusemide on renal haemodynamics and natriuresis in man. (1994) (8)
Renal effects of low dose prazosin in patients with congestive heart failure. (1993) (8)
Effects of contrast administration on cardiac MRI volumetric, flow and pulse wave velocity quantification using manual and software-based analysis (2017) (8)
Circulating angiotensin II and renal sodium handling in man: a dose-response study. (1993) (8)
Vasopeptidase inhibitors in heart failure. (2002) (8)
Atherosclerosis as a systemic feature of psoriasis (2011) (8)
Determinants of the initial effects of captopril on blood pressure, glomerular filtration rate, and natriuresis in mild-to-moderate chronic congestive heart failure secondary to coronary artery disease. (1994) (8)
Cardiovascular autonomic function in patients with hemodynamic instability at induction of capnoperitoneum: a case–control study (2004) (8)
The DD ACE gene polymorphism is associated with endothelial dysfunction in normal man (1999) (7)
Effect of captopril on changes in plasma noradrenaline induced by sodium nitroprusside. (1986) (7)
Effect of Vitamin D Supplementation on Blood Pressure A Systematic Review andMeta-analysis Incorporating Individual Patient Data (2015) (7)
Prevalence and Distribution of Atherosclerosis in a Low- to Intermediate-Risk Population: Assessment with Whole-Body MR Angiography. (2018) (7)
Impact of Left Ventricular Hypertrophy on Survival in Chronic Obstructive Pulmonary Disease (2015) (7)
Evidence for myocardial synthesis of aldosterone producing myocardial fibrosis in man. (2002) (7)
Dapagliflozin Improves Left Ventricular Myocardial Longitudinal Function in Patients With Type 2 Diabetes. (2020) (7)
Effect of ACE inhibitors on the atrial natriuretic peptides in heart failure. (1994) (7)
Diagnosing left ventricular dysfunction after myocardial infarction: the Dundee algorithm. (1997) (7)
Changing echocardiography request patterns between 1988 and 1993. (1996) (7)
Myocardial changes in incident haemodialysis patients over 6-months: an observational cardiac magnetic resonance imaging study (2017) (7)
and validation of a path length calculation for carotid-femoral pulse wave velocity measurement: a TASCFORCE, SUMMIT and Caerphilly collaborative venture. (2018) (7)
Whole body cardiovascular magnetic resonance imaging to stratify symptomatic and asymptomatic atherosclerotic burden in patients with isolated cardiovascular disease (2016) (7)
The effect of human atrial natriuretic peptide on urinary sodium and urinary dopamine excretion in man. (1985) (7)
Should we add screening for and treating left ventricular hypertrophy to the management of all patients needing secondary prevention of cardiovascular disease? (2003) (7)
The role of aldosterone in heart failure and the clinical benefits of aldosterone blockade (2004) (7)
Assessment of proximal pulmonary arterial stiffness using magnetic resonance imaging: effects of technique, age and exercise (2016) (7)
Systemic arteriosclerosis is associated with left ventricular remodeling but not atherosclerosis: a TASCFORCE study (2018) (7)
Captopril augments both basal and frusemide-induced natriuresis in normal man by suppression of circulating angiotensin II. (1992) (6)
Acute haemodynamic and renal effects of cyclosporin and indomethacin in man. (1994) (6)
Pathophysiology of aldosterone and its antagonists (2000) (6)
The influence of mode of delivery and ACE genotype on serum angiotensin converting enzyme (ACE) activity in the mother and infant at term. (2007) (6)
Identification, diagnosis and treatment of heart failure: could we do better? (1996) (6)
Cyclosporin-induced nephrotoxicity and hypertension. (1992) (6)
Diastolic dysfunction and ANP/BNP levels. (1996) (6)
Statin therapy increases vascular sensitivity to angiotensin II in hypercholesterolaemic patients (2004) (6)
QT-Dispersion Is Related to Sympathetic Tone After Acute Myocardial Infarction and in Chronic Heart Failure (1998) (6)
A Randomized, Controlled Trial of the Effect of Allopurinol on Left Ventricular Mass Index in Hemodialysis Patients (2020) (6)
Intermittent non-adherence with ACE inhibitor treatment and its implications for clinical trials results (2001) (6)
ATTITUDES OF PHYSICIANS IN THE TREATMENT OF CONGESTIVE HEART FAILURE IN OLDER ADULTS (1995) (6)
Biomarkers and surrogate endpoints in cardiovascular therapeutics research: under scrutiny following results of the ENHANCE Study. (2008) (5)
Health care delivery for chronic congestive heart failure in the United Kingdom (1994) (5)
Atrial natriuretic factor (1990) (5)
Renin-angiotensin system blockers are associated with reduced mortality and heart failure hospitalization in patients paced for complete atrioventricular block. (2012) (5)
The T allele of the C(677)T 5,10-methylenetetrahydrofolate reductase (MTHFR) gene polymorphism may protect endothelial function in young, normal subjects. (2002) (5)
More evidence for bedside BNP in heart failure assessment (2002) (5)
Adrenaline causes potassium influx in skeletal muscle and potassium efflux in cardiac muscle in rats: the role of Na/K ATPase. (1987) (5)
Does the aldosterone: renin ratio predict the efficacy of spironolactone over bendroflumethiazide in hypertension? A clinical trial protocol for RENALDO (RENin-ALDOsterone) study (2007) (5)
Dietary Sodium Loading Increases Plasma Brain Natriuretic Peptide Levels in Man (1991) (5)
Agreement between community echocardiography and hospital echocardiography in patients suspected of having left ventricular systolic dysfunction (2005) (5)
Diagnosis and management of heart failure: implications of the recent European Society of Cardiology Guidelines for the older patient. (2003) (5)
Sunday, 26 August 2012 (2012) (5)
Prior Treatment with Diuretic Augments the Hypokalaemic and Electrocardiographic Effects of Inhaled Salbutamol in Man (1989) (5)
Does everyone in heart failure need echocardiography? (2000) (4)
The effect of nitric oxide inhibition on the renin response to frusemide, in man. (1999) (4)
The effects of enalapril and spironolactone on terbutaline-induced hypokalemia. (1992) (4)
Arginine vasopressin dissociates the diuresis and natriuresis due to atrial natriuretic factor in man (1988) (4)
The accuracy of ECG screening by GPs and by machine interpretation in selecting suspected heart failure patients for echocardiography (2006) (4)
Research cardiac magnetic resonance imaging in end stage renal disease - incidence, significance and implications of unexpected incidental findings (2016) (4)
Abstract 19486: Younger Age at Time of Pacemaker Implantation is Associated With Worse Survival (2010) (4)
The Cardiovascular and Endocrine Effects of Human Calcitonin Gene Related Peptide (HCGRP) in Man (1985) (4)
An Open‐Label Dose‐Finding Study of Allopurinol to Target Defined Reduction in Urate Levels in Hemodialysis Patients (2017) (4)
The differential effects of circulating norepinephrine and neuronally released norepinephrine on sodium excretion in humans (1993) (4)
The effect of atrial natriuretic peptide on plasma renin activity, plasma aldosterone, and urinary dopamine in man (2004) (4)
Nifedipine does not influence adrenaline induced hypokalaemia in man. (1983) (4)
Abstract 10643: A Randomised Controlled Trial of Dapagliflozin on Left Ventricular Hypertrophy in Patients With Type Two Diabetes. The DAPA-LVH Trial (2019) (4)
QT Dispersion is Related to Autonomic Tone in Patients with Chronic Heart Failure (1997) (4)
Comparison of three methods of glomerular filtration rate measurement with and without captopril pretreatment in groups of patients with left ventricular dysfunction. (1992) (4)
Research into the Effect of Sodium-Glucose Linked Transporter 2 Inhibition on Left Ventricular Remodeling in Patients with Heart Failure and Diabetes Mellitus (2018) (4)
Assessment of central arterial pressure? Authors' reply (2003) (4)
Chapter 31 – Natriuretic Peptides (2007) (4)
Recruitment strategies for sarcopenia trials: lessons from the LACE randomized controlled trial (2021) (4)
N-terminal proBNP--the most cost effective way to identify post myocardial infarction left ventriular dysfunction? (2000) (4)
Effect of perindopril or leucine on physical performance in older people with sarcopenia: the LACE randomized controlled trial (2022) (4)
Global Array-Based Transcriptomics from Minimal Input RNA Utilising an Optimal RNA Isolation Process Combined with SPIA cDNA Probes (2011) (4)
Autonomic Effects of Spironolactone and MR Blockers in Heart Failure (2005) (4)
Nifedipine--studies on its mechanism of action and interaction with other circulatory control mechanisms in man. (1983) (4)
Diuretic use and abuse in systolic cardiac failure: a recipe for renal impairment? (2000) (4)
Nitric Oxide Regulates Renin Release During Salt Depletion but Does Not Alter Angiotensin Responses in Normal Humans (1999) (4)
Comparison of two methods of determining renal perfusion with and without captopril pretreatment in groups of patients with left ventricular dysfunction. (1994) (3)
6 Metformin regresses left ventricular hypertrophy in normotensive patients with coronary artery disease without type 2 diabetes mellitus – the met-remodel trial (2018) (3)
Aldosterone and artery compliance in heart failure. (1998) (3)
High B-Type Natriuretic Peptide Hypertensives at Target Blood Pressure: Potential Role of &bgr;-Blockers to Reduce Their Elevated Risk (2015) (3)
Raised plasma levels of atrial natriuretic factor in cardiac allograft recipients: evidence of increased cardiac secretion and decreased renal clearance (2004) (3)
Whole-body cardiovascular MRI for the comparison of atherosclerotic burden and cardiac remodelling in healthy South Asian and European adults (2016) (3)
Adrenaline Causes Potassium Influx in Skeletal Muscle but Potassium Efflux from Cardiac Muscle (1984) (3)
Theeffect ofprazosin on skinmicrocirculation asassessed by laser Doppler flowmetry (1988) (3)
Review: The potential benefits of aldosterone antagonism in Type 2 diabetes mellitus (2002) (3)
110 The effect of norepinephrine on renal sodium and water handling in euhydrated and overhydrated man (1993) (3)
Atrial Natriuretic Peptide (anp) Inhibits the Aldosterone Response to Angiotensin Ii in Man (1985) (3)
Disconnection of pulmonary and systemic arterial stiffness in COPD (2018) (3)
The source of BNP in rheumatoid arthritis. (2014) (3)
Follow-up of atheroma burden with sequential whole body contrast enhanced MR angiography: a feasibility study (2016) (3)
Effects of xamoterol in acute myocardial infarction: blood pressure, heart rate, arrhythmias and early clinical course. (1991) (3)
Spironolactone for People Age 70 Years and Older With Osteoarthritic Knee Pain: A Proof‐of‐Concept Trial (2015) (3)
C-type natriuretic peptide and vascular remodeling. (2001) (3)
Pentaerythrityl tetranitrate (PETN): a better nitrate? (2019) (3)
Inhaled corticosteroid therapy reduces the early morning peak in cortisol and aldosterone (1998) (3)
Novel Blockers of the Renin-Angiotensin-Aldosterone System in Chronic Heart Failure (2014) (3)
Brain natriuretic peptide testing for angina in a rapid-access chest pain clinic. (2007) (3)
Chronic Cardiac Failure (2010) (3)
Heart failure: a diagnostic and therapeutic dilemma in elderly patients. (1998) (3)
Atrial Natriuretic Factor Attenuates Prostaglandin E2‐Stimulated Plasma Renin Activity in Humans (1989) (3)
Monday, 27 August 2012 (2012) (3)
Polymorphisms of the angiotensin converting enzyme gene in relation to intrauterine growth restriction (2010) (3)
Physicians' Attitudes to the Treatment of Elevated Serum Cholesterol (1990) (2)
Using the demand-control model of job strain to predict caregiver burden:a longitudinal study (2005) (2)
Current cardiovascular drug therapy: Editors: G.A. Ewy and R. Bressler Raven Press, New York, 1984; 345 pp.; $22.00; ISBN 0-88167-012-X (1984) (2)
403 High dose allopurinol dramatically improves endothelial dysfunction more than conventional doses in chronic heart failure (2006) (2)
Endothelial function worsens with right ventricular pacing (2007) (2)
LOWERING URIC ACID IN NORMOURICAEMIC HYPERTENSIVE PATIENTS HAS AN ADVERSE EFFECT ON LEFT VENTRICULAR HYPERTROPHY REGRESSION (2019) (2)
The Assessment of Left Ventricular Systolic Function by Portable Echocardiography at the Day Hospital (1997) (2)
Thechoice ofantihypertensive therapy inthediabetic patient (1985) (2)
Atrial Natriuretic Peptide (1986) (2)
Reduction of blood pressure already in the normal range further regresses left ventricular mass (2010) (2)
Peripheral α2 Adrenoceptor Stimulation Contributes to the Sympatholytic Effect of Guanfacine in Humans (1985) (2)
EFFECT OF GLYCAEMIC CONTROL ON OUTCOME IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC HEART FAILURE (2015) (2)
Prevalence of symptomatic diastolic heart failure in patients hospitalized with cerebral or peripheral vascular disease. (2005) (2)
40 Clinical Utility of Combined Platelet Count and Neutrophil-to-Lymphocyte Ratio, a Simple Blood Test, in Predicting Outcome in Patients with Chronic Heart Failure (2015) (2)
Second International Stroke Summit (2006) (2)
Insulin Resistance in Heart Failure: Prevalence and Relation to Disease Severity (2007) (2)
Risk assessment of left ventricular systolic dysfunction in primary care. Drug treatment might be contaminating factor. (2000) (2)
The Effect of ANF on Urinary Protein Excretion in Man (1988) (2)
The Effect of Digoxin on Adrenaline Induced Hypokalaemia in Rabbits (1984) (2)
Tonic levels of angiotensin II reduce tonic levels of vascular nitric oxide even in salt-replete man (2004) (2)
Book reviewsThe alpha 1 adrenergic receptors: Edited by R.R. Ruffolo Humana Press (distributed by Wiley, Chichester, UK), 1988, 507 pp., £74.10 (1989) (2)
Handbook of hypertension, vol. 3:Editor: P.A. van Zwieten, Elsevier Science Publishers B.V., Amsterdam, 1984; 384 pp.; $99.00; ISBN 0-444-90313-5 (1984) (2)
Brain natriuretic peptide: its release and metabolism in man (1991) (2)
067 Metformin in insulin resistant LV dysfunction, a double-blind, placebo controlled trial (Tayside trial) (2010) (2)
Response to Letter Regarding Article, “The Effects of Vitamin D Supplementation on Physical Function and Quality of Life in Older Heart Failure Patients: A Randomized Controlled Trial” (2010) (2)
The effects of sildenafil on lung function in COPD (2012) (2)
MRI of the left atrium at 3T: evaluation of measurement reproducibility in healthy volunteers and patients with cardiovascular disease (2016) (2)
Effect of atrial natriuretic factor on platelet function in whole blood ex-vivo in man (2004) (2)
Effect of allopurinol on phosphocreatine recovery and muscle function in older people with impaired physical function: a randomised controlled trial (2020) (2)
Inhaled corticosteroid therapy reduces the early morning peak in cortisol and aldosterone. (1998) (2)
Patients' knowledge of non-pharmacological therapy of heart failure (2010) (1)
966-45 QT Dispersion in Essential Hypertension (1995) (1)
Adrenaline Induced Hypokalaemia is Increased by Treatment with Thiazide Diuretics (1983) (1)
50VITAMIN K TO IMPROVE MARKERS OF VASCULAR HEALTH AND PHYSICAL FUNCTION IN OLDER PEOPLE WITH VASCULAR DISEASE – A RANDOMISED CONTROLLED TRIAL (2014) (1)
Renal interactions between the renin-angiotensin system and the sympathetic nervous system in man. (1991) (1)
Investigation in general practice of patients with suspected heart failure. How should the essential echocardiographic service be delivered? (1995) (1)
UNDERUTILIZATION OF ACE INHIBITORS IN OLDER PERSONS (1999) (1)
British Society of Cardiovascular Imaging / British Society of Cardiovascular CT (2016) (1)
Tuesday, 28 August 2012 (2012) (1)
Allopurinol reduces RV mass in patients with severe COPD (2018) (1)
Angiotensin II receptor blockers in chronic heart failure - Not as ELITE as expected! (2000) (1)
Do phosphodiesterase 5 inhibitors improve exercise capacity in patients with COPD associated pulmonary hypertension? (3P study) (2013) (1)
Abstract 12197: Angiotensin-Converting Enzyme Inhibitors Are Associated with Better All-Cause Mortality and Improved Cardiovascular Outcome in Aortic Stenosis (2010) (1)
Non-genomic actions of aldosterone: a possible role in sudden cardiac death (2002) (1)
The effect of glyceryl trinitrate ointment on heart rate--corrected systolic time intervals in angina pectoris. (1982) (1)
Calcitonin Gene???Related Peptide (CGRP): The Most Potent Endogenous Vasodilator in Man (1985) (1)
The Pattern of Release of Brain Natriuretic Peptide is Different from Atrial Natriuretic Peptide During an Acute Saline Load in Man (1992) (1)
Acceptability and feasibility of magnetic femoral nerve stimulation in older, functionally impaired patients (2018) (1)
Other medical conditions (2013) (1)
Aldosterone : an important mediator of cardiac remodelling in heart failure (2005) (1)
Allopurinol regresses left ventricular hypertrophy especially in those with highest left ventricular mass (2013) (1)
C012: Exercise systolic blood pressure is an independent predictor of corrected maximum QT interval in hypertension (2000) (1)
QT-Dispersion during Life is Closely Related to Collagen Volume Fraction at Autopsy (1999) (1)
009 ADHERENCE TO HEART FAILURE THERAPY AND OUTCOME: A POPULATION BASED STUDY (2013) (1)
The impact of angiotensin converting enzyme inhibitors in aortic valve disease (2011) (1)
Non adherence with therapy is common in heart failure and can be detected in routine practice by serum ACE activity (1999) (1)
The Assessment of Left Ventricular Function by Echocardiography (1995) (1)
Metformin use is associated with markedly lower clinical outcomes in patients with heart failure and type II diabetes. (2008) (1)
Effect of exercise on the nasal transmucosal potential difference in patients with cystic fibrosis and normal subjects (1)
Effect of vitamin D supplementation on orthostatic hypotension–data from the VitDISH trial (2013) (1)
Can endothelial function be assessed in vivo by measuring acetylcholine induced changes in nitrate in the forearm in man? (1998) (1)
667 EFFECT OF LEUCINE SUPPLEMENTATION ON PHYSICAL PERFORMANCE, MUSCLE MASS AND QUALITY OF LIFE IN OLDER PEOPLE WITH SARCOPENIA (2022) (1)
The effect of ACE inhibitors and atrial natriuretic factor on the cardiorenal axis in man. (1992) (1)
Blood pressure, left ventricular hypertrophy and cardiovascular disease (2010) (1)
011 HbA1c and mortality in diabetic individuals with heart failure: an observational cohort study (2012) (1)
FP802EFFECT OF ALLOPURINOL ON LEFT VENTRICULAR MASS INDEX IN HAEMODIALYSIS PATIENTS - A RANDOMISED CONTROLLED TRIAL (2018) (1)
Algorithm to detect left ventricular dysfunction after myocardial infarction (1996) (1)
Metformin in insulin resistant LV dysfunction, a double-blind, placebo controlled trial (TAYSIDE trial) (2010) (1)
Towards Understanding the Clinical Significance of Qt Peak Prolongation- A Novel Marker of Myocardial Ischemia Independently Demonstrated in Two Prospective Studies (2015) (1)
Letter to the editor: Comparing pace and speed in the pulmonary circulation? (2016) (1)
Are Angiotensin Converting Enzyme Inhibitors a New Therapeutic Option in Hypercholesterolaemia (1997) (1)
159 ALLOPURINOL REDUCES LEFT VENTRICULAR MASS IN PATIENTS WITH TYPE 2 DIABETES AND LEFT VENTRICULAR HYPERTROPHY (2013) (1)
QTc dispersion and risk of cardiac death in peripheral vascular disease. (1996) (1)
Are elderly people with the HOPE criteria prescribed angiotensin-converting enzyme inhibitors? (2004) (1)
Natriuretic mechanisms of atrial peptide in man (1988) (1)
Allopurinol in Patients with Pulmonary Hypertension Associated with Chronic Lung Disease (2020) (1)
Genetic variants predicting left ventricular hypertrophy in a diabetic population (2013) (1)
Are Brain Natriuretic Peptide Levels Related to Flow through Autologous Aterio-Venous Fistulae for Chronic Haemodialysis? (2012) (1)
Does Pituitary and Adrenocortical Hormone Release in Man Depend on, Transmembrane Calcium Flux? (1982) (1)
Careful screening to target interventions to prevent sudden cardiac death. (2001) (1)
The Place of Angiotensin-Converting Enzyme Inhibitors in Internal Medicine (1989) (1)
Human C-Type Natriuretic Peptide: Effects on the Haemodynamic and Hormonal Responses to Angiotensin Ii (1995) (1)
The present and future role of aldosterone blockade (2004) (1)
The Value of Natriuretic Peptides in Confirming the Diagnosis of New Heart Failure in General Practice (1997) (1)
63EVALUATION OF GDF-15 AS A CANDIDATE BIOMARKER FOR HEALTH AND VASCULAR FUNCTION IN OLDER PATIENTS WITH HYPERTENSION (2016) (0)
Indomethacin Augments Cyclosporin Induced Nephrotoxicity in Man (1993) (0)
Warfarin Use is Associated With Reduced Mortality in Patients with Left Ventricular Systolic Dysfunction and Pulmonary Hypertension Ventricular Systolic Dysfunction and Pulmonary Hypertension (2011) (0)
Diuretic treatment in those dying from a myocardial infarction (1992) (0)
Effect of metformin on epicardial adipose tissue in patients with coronary artery disease without diabetes: A cardiac MRI substudy of the MET-remodel trial (2021) (0)
Right Ventricular Pacing is Associated with Impaired Endothelial Function (2007) (0)
Intrarenal sites of action of atrial natriuretic factor in man (1988) (0)
The incidence and risk of biochemical recurrence following radical radiotherapy for prostate cancer in men on Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin Receptor Blockers (ARB) (2016) (0)
MP50-10 THE INCIDENCE AND RISK OF BIOCHEMICAL RECURRENCE FOLLOWING RADICAL RADIOTHERAPY FOR PROSTATE CANCER IN MEN ON ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACEIS) OR ANGIOTENSIN RECEPTOR BLOCKERS (ARB) (2016) (0)
Abstract 3144: Prevalence Of Insulin Resistance Among Non-diabetic Chronic Heart Failure Patients And Its Relation To Disease Severity (2007) (0)
Anatomical Phenotype or Distinct Cardiomyopathy ? (2016) (0)
Right Ventricular Pacing Worsens Endothelial Function (2007) (0)
025 Determinants of pulmonary arterial remodelling in copd and implications for right ventricular remodelling (2017) (0)
Update on heart failure (2011) (0)
42 Is Mitochondrial Function Measured by 31P Magnetic Resonance Spectroscopy Associated with Physical Performance in Older People with Functional Impairment? (2021) (0)
The effect of angiotensin II and noradrenaline alone and in combination on renal sodium excretion in man. (1989) (0)
Abstract 15218: Neutrophil to Lymphocyte ratio Predicts All-cause Mortality in Patients with Chronic Heart Failure (2014) (0)
101 What degree of pulmonary hypertension predicts poor outcome in patients with left ventricular systolic dysfunction? A 10-year follow-up study (2011) (0)
tissues in the body including the brain, vascular tissue, and the myocardium. (2004) (0)
Leucine and perindopril to improve physical performance in people over 70 years with sarcopenia: the LACE factorial RCT (2022) (0)
Prevalence and Distribution of atherosclerosis in a low- to intermediate-risk Population: Assessment with Whole-Body MR Angiography 1 (2018) (0)
Should hospitals have a designated consultant with a specific interest in heart failure? (2003) (0)
University of Dundee Global Array-Based Transcriptomics from Minimal Input RNA Utilising an Optimal RNA Isolation Process Combined with SPIA cDNA Probes Kennedy, (2011) (0)
948-48 High-dose Lisinopril is More Effective than Low-dose in Suppressing Aldosterone in Patients with Chronic Heart Failure (1995) (0)
The Effect of Angiotensin-Converting-Enzyme Inhibition on Plasma Brain Natriuretic Peptide Levels in Congestive Heart Failure Patients (1992) (0)
Diuretic Treatment and Myocardial Infarction (1989) (0)
University of Dundee Common carotid intima media thickness and ankle-brachial pressure index correlate with local but not global atheroma burden Weir-McCall, (2014) (0)
Looking at non-genomic vascular effects of aldosterone. (2004) (0)
end-stage renal failure with cardiac magnetic De fi ning myocardial tissue abnormalities in resonance imaging using native T 1 mapping (2016) (0)
LETTERS TO THE EDITORS (1985) (0)
CAN MICROALBUMINURIA IDENTIFY SILENT ‘PANCARDIAC’ TARGET ORGAN DAMAGE IN A NON-DIABETIC PRIMARY PREVENTION POPULATION? (2011) (0)
139 CARDIAC TROPONIN-T MEASURED BY HIGH SENSITIVITY ASSAY AND ITS ASSOCIATION WITH REVERSIBLE MYOCARDIAL ISCHAEMIA IN PATIENTS WITH AND WITHOUT LV SYSTOLIC DYSFUNCTION (2013) (0)
The Effect of Metformin and Dapagliflozin on Epicardial Adipose Tissue in Prediabetes and Type 2 Diabetic Patients (2018) (0)
Acquisition of echo-Doppler parameters of pulmonary hypertension in COPD (2012) (0)
Abstract 4517: High Dose Allopurinol is Anti-Ischaemic in Chronic Stable Angina (2009) (0)
Serum angiotensin-converting enzyme assays should be ubiquitously available. (2003) (0)
The prevalence and predictors of left ventricular hypertrophy in patients with rheumatoid arthritis (2011) (0)
Serum Sodium and Its Impact on Outcome in Patients Hospitalized for Heart Failure (SODIUM-HF) Study (2009) (0)
Low dose atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) with spironolactone in the treatment of ascites (1998) (0)
Atherosclerosis as a systemic feature of psoriasis 1 (2011) (0)
Aldosterone blockade with spironolactone suppresses vascular ACE and improves endothelial function in patients with chronic heart failure (1999) (0)
129 The prognostic; value of a 7-week high sensitivity Troponin T level after an acute coronary syndrome (2012) (0)
Vitamin K supplementation to improve vascular stiffness in chronic kidney disease - the K4Kidneys randomised controlled trial (2020) (0)
Allopurinol improves endothelial dysfunction by ameliorating vascular oxidative stress in patients with chronic stable angina on optimum medical therapy (2008) (0)
The impact of metformin in non-diabetic insulin-resistant chronic heart failure (2011) (0)
Heart failure ALDOSTERONE BLOCKADE IN CARDIOVASCULAR DISEASE (2004) (0)
Spironolactone Suppresses Vascular Ace and Improves Endothelial Dysfunction in Patients with Chronic Heart Failure (1999) (0)
142Insulin resistance, left ventricular hypertrophy and the impact of metformin use on cardiovascular outcomes in patients with calcific aortic stenosis: a genetic and population cohort study (2018) (0)
Nurse-led clinics for the secondary prevention of coronary heart disease: ten year follow-up of a randomised trial in primary care Development and validation of a clinical prediction rule (CPR) for Left Ventricular Systolic Dysfunction (LVSD) in primary care (2006) (0)
014 Patterns of early atherosclerosis formation and cardiac remodelling in healthy adults of south asian and european descent (2016) (0)
CV4: THE INFLUENCE OF NON-CARDIAC VASCULAR DISEASE ON THE COST-EFFECTIVENESS OF SCREENING FOR LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (LVSD) (2000) (0)
Abstract 11934: High Sensitivity Cardiac Troponin T is Associated with Silent Cardiac Target Organ Damage in Asymptomatic Primary Prevention Patients (2011) (0)
Allopurinol Improves Endothelial Function in NIDDM, but has no Effect in Aged-matched and Young Non-diabetic Controls (1998) (0)
050 A novel role for b-type natriuretic peptide (BNP) as a safe and effective rule-out test in patients referred to rapid access chest pain clinics; results of a large, prospective 1-year follow-up study (2010) (0)
Abstract 3029: Endothelial Function Worsens with Right Ventricular Pacing. (2007) (0)
Identifying older heart failure patients with major depression in primary care: a feasibility study (2014) (0)
Systemic Nitric Oxide Inhibition Increases Insulin Sensitivity in Man (1997) (0)
Effect of metformin on mortality and hospitalisations in patients with heart failure and type 2 diabetes (2008) (0)
Reducing cardiovascular Risk in patients Following MI with eplerenone (2010) (0)
Does vitamin D supplementation improve markers of vascular health in post myocardial infarction patients?: a randomised controlled trial (2012) (0)
Using biomarkers to identify diabetic patients with multiple silent cardiac abnormalities (2020) (0)
A natural mini polypill: Potential impact on population cardiovascular risk of a daily drink of milk (2017) (0)
Captopril Inhibits Frusemide Induced Natriuresis in Ambulant Heart Failure Patients (1989) (0)
Episiotomy and faecal incontinence (1999) (0)
Comparison of the effects of ANF 99–126 and ANF 103–126 on captopril‐induced renin release in man (1991) (0)
CAN B-TYPE NATRIURETIC PEPTIDE IDENTIFY STRESS INDUCED MYOCARDIAL ISCHEMIA IN THE PRESENCE OF SYSTOLIC DYSFUNCTION? (2011) (0)
QT Peak Prolongation Predicts Cardiac Death Following Stroke (2015) (0)
Noradrenaline Attenuates the Natriuretic Effect of ANF in Man (1988) (0)
University of Dundee Renal and Cardiovascular Effects of SGLT2 inhibition in combination with loop Diuretics in patients with Type 2 Diabetes and Chronic Heart Failure Mordi, (2020) (0)
The BP response to the first dose of captopril: Does the dose size matter and does it predict the BP response to subsequent doses? (1990) (0)
168 β-Blocker therapy improves clinical outcomes in patients with moderate to severe mitral regurgitation (2011) (0)
Screening for and treatment of left-ventricular abnormalities in diabetes mellitus [3] (multiple letters) (2002) (0)
Review: Aldosterone antagonism in type 2 diabetes mellitus — a new therapeutic approach to diabetic macrovascular disease? (2008) (0)
Left ventricular hypertrophy in 'normotensive' individuals: would further reduction in blood pressure enhance regression of LVH? (2008) (0)
Association between mitochondrial function measured by 31P magnetic resonance spectroscopy and physical performance in older people with functional impairment (2021) (0)
University of Dundee A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes (2019) (0)
Abstract 14087: B-Type Natriuretic Peptide Identifies Silent Cardiac Target Organ Damage in Asymptomatic Primary Prevention Patients (2010) (0)
Predicting Ejection Fraction after Myocardial Infarction (1995) (0)
High-dose allopurinol prolongs time to exercise-induced ischaemia in chronic stable angina (2009) (0)
136 HIGH DOSE ALLOPURINOL IMPROVES ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHAEMIC HEART DISEASE AND LEFT VENTRICULAR HYPERTROPHY BUT DOES NOT MATCH AGE AND GENDER MATCHED CONTROLS (2013) (0)
39 Aldosterone antagonists (2011) (0)
AB1029 Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease (ALL-HEART) study: baseline characteristics of the randomised patient population (2018) (0)
Acute cyclosporin reduces urinary water output and increase blood pressure before renal blood flow and renal sodium output are affected. (1993) (0)
Vitamin D improves markers of vascular health in patients with type 2 diabetes (2007) (0)
Annual scientific meeting of the British Hypertension Society. Cambridge, United Kingdom, 20th-21st September 1983. Abstracts. (1983) (0)
PO022 Metformin and Dapagliflozin Effects On Epicardial Adipose Tissue Area In Prediabetes and Type 2 Diabetes Patients: MRI Evaluation Studies (2018) (0)
University of Dundee Xanthine oxidase inhibition for the improvement of long-term outcomes following ischaemic stroke and transient ischaemic attack ( XILO-FIST )-Protocol for a randomised double blind placebo-controlled clinical trial (2018) (0)
University of Dundee 3 T MRI investigation of cardiac left ventricular structure and function in a UK population (2016) (0)
PREDICTING EJECTION FRACTION AFTER MYOCARDIAL INFARCTION. AUTHORS' REPLY (1995) (0)
204 Cyclosporin increases blood pressure before there is any change in sodium excretion or glomerular filtration rate (1993) (0)
High frequency of co‐morbidity and polypharmacy in elderly heart failure patients (2000) (0)
666 EFFECT OF PERINDOPRIL ON PHYSICAL PERFORMANCE, MUSCLE MASS AND QUALITY OF LIFE IN OLDER PEOPLE WITH SARCOPENIA: RESULTS: FROM THE (2022) (0)
Renal sodium handling in man: role of the renal sympathetic nervous system (1990) (0)
University of Dundee Leucine and ACE inhibitors as therapies for sarcopenia ( LACE trial ) (2018) (0)
Addition of B-type natriuretic peptide to the thrombolyisis in myocardial infarction risk score enhances risk stratification in acute coronary syndrome (2008) (0)
Reply. (2020) (0)
Myocardial fibrosis in stroke survivors. (2015) (0)
Tayside Screening For Cardiac Events (TASCFORCE) study: a prospective cardiovascular risk screening study (2022) (0)
Clinical case studies in heart failure management. (1999) (0)
TO034NON-CONTRAST CARDIAC MAGNETIC RESONANCE T1 MAPPING AS A MARKER OF MYOCARDIAL FIBROSIS IN END STAGE RENAL DISEASE (2016) (0)
54 Can microalbuminuria identify silent “pancardiac” target organ damage in a non-diabetic primary prevention population? (2011) (0)
P2860MRI evaluation of the impact of metformin and dapagloflizin on epicardial adipose tissue area in prediabetes and type 2 diabetes patients (2018) (0)
Reply: The Enigma of Left Ventricular Non-Compaction. (2017) (0)
The prevalence of left ventricular hypertrophy in stable treated angina pectoris patients (2007) (0)
14 Effects of cardiovascular disease on the arterial pathlength between the carotid and femoral arteries (2017) (0)
Clinical Research A Randomized Controlled Trial of Allopurinol in Patients With Peripheral Arterial Disease (2016) (0)
Angiotensin converting enzyme inhibitor use is associated with reduced mortality in patients with aortic regurgitation (2011) (0)
Treatable Left Ventricular Dysfunction in Patients with Acute Cerebrovascular Disease (1999) (0)
Atrial natriuretic factor may have a specific anti-cyclosporin A effect in man (1993) (0)
Opioids for treating dyspnoea in patients with chronic heart failure (2016) (0)
Xanthine Oxidase Inhibition And White Matter Hyperintensity Progression Following Ischaemic Stroke and Transient Ischaemic Attack; The XILO-FIST Randomised Placebo Controlled Trial (2022) (0)
Authors' reply (1996) (0)
Thiazides, α-and β-blockers, and dopaminergic drugs (1989) (0)
University of Dundee Prevalence of unrecognised myocardial infarction in a low-intermediate risk asymptomatic cohort and its relation to systemic atherosclerosis Weir-McCall, (2016) (0)
49EFFECT OF ALLOPURINOL ON SKELETAL MUSCLE PHOSPHOCREATINE RECOVERY RATE AND PHYSICAL FUNCTION IN OLDER PEOPLE WITH IMPAIRED PHYSICAL FUNCTION: A RANDOMISED CONTROLLED TRIAL (2019) (0)
Pathophysiology and prevalence of insulin resistance among non-diabetic chronic heart failure patients and its relation to disease severity (2008) (0)
Angiotensin converting enzyme inhibition improves endothelial dysfunction in chronic cigarette smokers (1999) (0)
Acute and chronic effects of PDE5-Is on SpO2 in patients with COPD associated pulmonary hypertension (2013) (0)
BNP PREDICTS FUTURE INCREASES IN LEFT VENTRICULAR MASS IN A PRIMARY PREVENTION POPULATION (2014) (0)
572 An appraisal of different ways of selecting patients with suspected heart failure for echocardiography (2005) (0)
Xanthine oxidase inhibition and white matter hyperintensity progression following ischaemic stroke and transient ischaemic attack (XILO-FIST): a multicentre, double-blinded, randomised, placebo-controlled trial (2023) (0)
The Use of Brain Natriuretic Peptide in Aortic Stenosis and Hypertrophic Cardiomyopathy to Asses Outflow Tract Gradients (1994) (0)
2358Metformin regresses left ventricular hypertrophy in normotensive patients with coronary artery disease without type 2 diabetes mellitus - The MET-REMODEL trialM (2018) (0)
887-5 Diastolic heart failure in patients hospitalized with symptomatic cerebral and peripheral vascular disease (2004) (0)
Serial haemoglobin measures after acute coronary syndrome: a strong, simple and independent predictor of long-term cardiovascular outcome (2009) (0)
Endogenous xanthine oxidase causes profound vascular oxidative stress and widespread endothelial dysfunction in chronic stable angina patients despite contemporary therapy (2008) (0)
Abstract 10324: The Effect of Allopurinol on B-Type Natriuretic Peptide Levels in Patients with Chronic Stable Angina (2010) (0)
168 b-BLOCKER THERAPY IMPROVES CLINICAL OUTCOMES IN PATIENTS WITH MODERATE TO SEVERE MITRAL (2011) (0)
The Authors9 response (2010) (0)
Serum concentration of bone tissue metabolism markers in 28 and 180-day-old Polish Large White pigs (2014) (0)
015 Prevalence, pattern and significance of late gadolinium enhancement in a healthy asymptomatic cohort (2016) (0)
Letter by Singh et al Regarding Article, "Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)". (2021) (0)
Screening for and treatment of left-ventricular abnormalities in diabetes mellitus. Authors' reply (2002) (0)
Letter by Struthers et al regarding article, "cross-sectional relations of multiple biomarkers from distinct biological pathways to brachial artery endothelial function". (2006) (0)
Acceptability and feasibility of magnetic femoral nerve stimulation in older, functionally impaired patients (2018) (0)
High Dose Allopurinol is Anti-Ischaemic in Chronic Stable Angina (2009) (0)
P20 A comparison of the cardiovascular effects of empagliflozin and liraglutide: a systematic review and meta-analysis (2016) (0)
High prevalence of asymptomatic left ventricular diastolic dysfunction and its detection among South Asian patients with Type 2 Diabetes Mellitus compared with White Europeans (2022) (0)
Aldosterone blockade in heart failure (2004) (0)
The effect of spironolactone on pulse wave characteristics in hypertension: influence of the aldosterone to renin ratio (ARR) (2007) (0)
Systemic and Pulmonary Haemodynamic Effects of Endothelin-1 in Humans (1996) (0)
Acute Falls of Plasma Potassium in Squash Players (1984) (0)
Abstract 19588: How High Is Too High? - What Degree of Pulmonary Hypertension Predicts Poor Outcome In Patients With Left Ventricular Systolic Dysfunction ? (2010) (0)
53 B-type natriuretic peptide performs better than current cardiovascular risk scores in identifying silent “pancardiac” target organ damage in already treated primary prevention patients (2011) (0)
102EFFECT OF VITAMIN D SUPPLEMENTATION ON ORTHOSTATIC HYPOTENSION – DATA FROM THE VITDISH TRIAL (2014) (0)
The haemodynamic effects of labetalol under conditions of increased levels of circulating catecholamines. (1983) (0)
15 No association between systemic arteriosclerosis and atherosclerosis on cardiac MRI and whole body angiography: the tascforce study (2017) (0)
ACE inhibition improves exercise capacity in functionally impaired older people without heart failure (2008) (0)
COPD_A_260917 2015..2024 (2020) (0)
Captopril Therapy in Chronic Heart Failure: Does the Size of the First Dose Matter? (1990) (0)
52 Brain natriuretic peptide predicts all cause mortality in patients with type 2 diabetes and normal ejection fractions (2011) (0)
Neuroendocrine-Renal Relationships in Heart Failure: Effect of Captopril (1991) (0)
The addition of spironolactone further improves heart rate variability (HRV) in CHF patients treated with ACE inhibitors and loop diuretics (1996) (0)
Dapagliflozin improves left ventricular myocardial longitudinal function in people with type 2 diabetes (2020) (0)
P905Research into the effect of sodium-glucose linked transporter inhibition in left ventricular remodelling in patients with heart failure and diabetes mellitus (2018) (0)
Authors' response (2010) (0)
High-dose allopurinol in patients with stable angina pectoris – Authors' reply (2010) (0)
112 B-type Natriuretic Peptide is Associated with Future Rise in Lv Mass in Optimally Treated Primary Prevention Population (2014) (0)
in muscle oxidative capacity or contractile phenotype response to endurance training in rats, without change Decreased muscle ACE activity enhances functional (2015) (0)
A Photosensitizer-Growth Factor Conjugate as a Potential Targetting Agent for the Photodynamic Therapy of Tumours (1991) (0)
Sensitivity andspecificity ofQTcdispersion foridentification ofrisk ofcardiac death inpatients withperipheral vascular disease (1996) (0)
Effect of vitamin D supplementation on markers of vascular function (2018) (0)
Annual Scientific Meeting of the British Hypertension Society (2007) (0)
High sensitivity troponin T provides useful prognostic information in non-acute chest pain. (2012) (0)
Grossly elevated serum angiotensin-converting enzyme activities are still suppressible with ACE inhibitor therapy (2002) (0)
Abstract 18290: Warfarin Use is Associated With Reduced Mortality in Patients with Left Ventricular Systolic Dysfunction and Pulmonary Hypertension (2011) (0)
PIII‐25 (2006) (0)
Abstract 12587: Glycaemic Control and the Development of Heart Failure in Diabetic Patients with Left Ventricular Systolic Dysfunction on Echocardiography. (2010) (0)
Effect of short term ace inhibition on physical function in older people: a follow up study (2009) (0)
Cyclosporin Increases Blood Pressure Acutely and before there is any Sodium Retention (1993) (0)
University of Dundee Assessment of proximal pulmonary arterial stiffness using magnetic resonance imaging (2016) (0)
Insulin does not contribute to adrenaline induced hypokalaemia (1985) (0)
PROGNOSTIC ROLE OF COMBINED PLATELET COUNT AND NEUTROPHIL-TO-LYMPHOCYTE RATIO IN PREDICTING OUTCOME IN PATIENTS WITH CHRONIC HEART FAILURE (2015) (0)
Ecg and systemic responses to inhaled salbutamol are due to pulmonary rather than gut absorption (1989) (0)
Abstract 14498: Allopurinol Reduces Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiorenal Patients (2010) (0)
576 Predicting which patients with symptoms and signs of heart failure require an echocardiogram (2005) (0)
A randomised controlled trial of exercise training for older heart failure patients (2011) (0)
Endothelial Vasodilator Dysfunction in Chronic Heart Failure Pattents is Improved by Allopurinol (1999) (0)
16 Pulmonary arterial stiffness in COPD: pulmonary biomarker or another measure of systemic arteriosclerosis? (2017) (0)
SP538EXPLORATION OF RIGHT VENTRICULAR HAEMODYNAMICS IN HAEMODIALYSIS PATIENTS USING CARDIAC MAGNETIC RESONANCE IMAGING (2017) (0)
Chronic cigarette smoking is associated with impaired basal and stimulated nitric oxide release in young men (1998) (0)
Does the aldosterone: renin ratio (ARR) predict the efficacy of spironolactone over bendroflumethiazide in hypertension? The RENALDO study (2008) (0)
20 Rapid effects of aldosterone on forearm vasculature in chronic heart failure (2004) (0)
Myocardial changes in incident haemodialysis patients over 6-months: an observational cardiac magnetic resonance imaging study (2017) (0)
The Effects of Triamterene and Spironolactone on the Hypokalaemic and Ecg Sequelae of Bendrofluazide and Inhaled Salbutamol (1990) (0)
Predicting fitness and activity in congestive heart failure: Application of the theory of planned behaviour in RCT of exercise (2005) (0)
Novel Therapeutic Concepts Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction : integrating evidence into clinical practice (2012) (0)
Prazosin Blunts Both the Antinatriuretic Effect of Angiotensin II and the Natriuretic Effect of Anf in Man (1990) (0)
Metabolic andhaemodynamic effects ofincreased circulating adrenaline inman Effect oflabetalol, analpha andbeta blocker (1983) (0)
Abstract 17538: Baseline High Sensitivity Cardiac Troponin-T Can Identify Reversible Myocardial Ischemia Even in the Presence of LV Systolic Dysfunction (2012) (0)
Atrial fibrillation in diabetes: A cause for concern? (2012) (0)
Comparison of the endurance shuttle walk test and the six-minute walk test in older heart failure patients (2011) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Allan D. Struthers?

Allan D. Struthers is affiliated with the following schools:

Allan D. Struthers's Academic­Influence.com Rankings

Allan D. Struthers's Degrees

Similar Degrees You Can Earn

Why Is Allan D. Struthers Influential?

Allan D. Struthers's Published Works

Published Works

What Schools Are Affiliated With Allan D. Struthers?

Allan D. Struthers's AcademicInfluence.com Rankings